The United States Patent Office has issued a U.S. Patent for the SeroVital formula, an oral growth hormone booster that’s been clinically validated to raise mean, serum (blood) hGH levels by 682%.

Here’smore about SeroVital, and what its packaging looks like.

Human growth hormone (hGH) therapy is one of the most talked about “youth” therapies available today. Allure magazine, in its “Anti-aging Special” issue, highlighted growth hormone as its 2013 call-out.

Shape magazine began a recent growth hormone article with the provocative lead in: “When you see a 50-year-old actress who can pass for 35, you can bet that good genes aren’t the only things responsible for her youthful glow.”

“We are extremely excited about being granted this patent,” says Chantelle Daines, spokesperson for SanMedica International, SeroVital’s distributor. “There are hundreds of products on the market that claim to increase growth hormone levels without injections. We’re very proud to receive the distinction of having a United States Patent that protects our SeroVital formula from imitators.”

SeroVital makes it possible for people to increase their human growth hormone levels through an entirely different approach than hGH injections offer.

United States Patent Number 8,551,542 protects the SeroVital formula as a method and composition for increasing growth hormone.